Literature DB >> 16164620

Progression of microalbuminuria in type 1 diabetes: ten-year prospective observational study.

Peter Rossing1, Philip Hougaard, Hans-Henrik Parving.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 16164620     DOI: 10.1111/j.1523-1755.2005.00556.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  27 in total

Review 1.  Does familial clustering of risk factors for long-term diabetic complications leave any place for genes that act independently?

Authors:  Andrew D Paterson; Shelley B Bull
Journal:  J Cardiovasc Transl Res       Date:  2012-06-23       Impact factor: 4.132

2.  Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005.

Authors:  P Rossing
Journal:  Diabetologia       Date:  2005-12-09       Impact factor: 10.122

Review 3.  Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential.

Authors:  Danyi Yang; Man J Livingston; Zhiwen Liu; Guie Dong; Ming Zhang; Jian-Kang Chen; Zheng Dong
Journal:  Cell Mol Life Sci       Date:  2017-09-04       Impact factor: 9.261

4.  Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014.

Authors:  Maryam Afkarian; Leila R Zelnick; Yoshio N Hall; Patrick J Heagerty; Katherine Tuttle; Noel S Weiss; Ian H de Boer
Journal:  JAMA       Date:  2016-08-09       Impact factor: 56.272

Review 5.  Why do some patients with type 1 diabetes live so long?

Authors:  Larry A Distiller
Journal:  World J Diabetes       Date:  2014-06-15

6.  Long-term prevention of diabetic nephropathy: an audit.

Authors:  K J Schjoedt; H P Hansen; L Tarnow; P Rossing; H-H Parving
Journal:  Diabetologia       Date:  2008-04-03       Impact factor: 10.122

Review 7.  Urinary Proteomics for Diagnosis and Monitoring of Diabetic Nephropathy.

Authors:  G Currie; C Delles
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

Review 8.  Diabetic nephropathy in children and adolescents.

Authors:  Radovan Bogdanović
Journal:  Pediatr Nephrol       Date:  2007-10-17       Impact factor: 3.714

9.  YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria.

Authors:  Camilla Noelle Rathcke; Frederik Persson; Lise Tarnow; Peter Rossing; Henrik Vestergaard
Journal:  Diabetes Care       Date:  2008-10-28       Impact factor: 19.112

Review 10.  YKL-40--an emerging biomarker in cardiovascular disease and diabetes.

Authors:  Camilla N Rathcke; Henrik Vestergaard
Journal:  Cardiovasc Diabetol       Date:  2009-11-23       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.